Veterinary Medicines

PA-OLVAC+PM+I Vaccino inattivato in emulsione iniettabile per tacchini

Authorised
  • Newcastle disease virus, Inactivated
  • Influenza A virus, subtype H9N2 (avian), Inactivated
  • Influenza A virus, subtype H6N2 (avian), Inactivated
  • Pasteurella multocida, Inactivated
  • Riemerella anatipestifer, serotype 3, Inactivated
  • Riemerella anatipestifer, serotype 1, Inactivated
Download as PDF

Product identification

Medicine name:
PA-OLVAC+PM+I Vaccino inattivato in emulsione iniettabile per tacchini
Active substance:
  • Newcastle disease virus, Inactivated
  • Influenza A virus, subtype H9N2 (avian), Inactivated
  • Influenza A virus, subtype H6N2 (avian), Inactivated
  • Pasteurella multocida, Inactivated
  • Riemerella anatipestifer, serotype 3, Inactivated
  • Riemerella anatipestifer, serotype 1, Inactivated
Target species:
  • Turkey
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Newcastle disease virus, Inactivated
    50.00
    50% Protective Dose
    /
    0.50
    millilitre(s)
  • Influenza A virus, subtype H9N2 (avian), Inactivated
  • Influenza A virus, subtype H6N2 (avian), Inactivated
  • Pasteurella multocida, Inactivated
    1.00
    billion colony forming units
    /
    0.50
    millilitre(s)
  • Riemerella anatipestifer, serotype 3, Inactivated
    1.00
    billion colony forming units
    /
    0.50
    millilitre(s)
  • Riemerella anatipestifer, serotype 1, Inactivated
    1.00
    billion colony forming units
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Turkey
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01CL
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
  • Fatro S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 102359
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."